Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer
Condition(s):Pancreatic Cancer; Benign Pancreatic DiseaseLast Updated:November 14, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Pancreatic Cancer; Benign Pancreatic DiseaseLast Updated:November 14, 2023Recruiting
Condition(s):Pancreatic CancerLast Updated:September 6, 2023Completed
Condition(s):Ampullary Cancer; Duodenal Cancer; Bile Duct Cancer; Bile Duct Disorders; Gallstones; Obstructive Jaundice; Pancreatic Disorders (Noncancerous); Colorectal Cancer; Esophageal Cancer; Barrett’s Esophagus; Gastric Malignancies; Pancreatic Cancer; Pediatric Gastroenterology; Cholangiocarcinoma; Pancreatic Pseudocysts; Acute and Chronic Pancreatitis; Recurrent Pancreatitis; Cholangitis; Bile Leak; Biliary Strictures; Pancreatic Divisum; Biliary and Pancreatic Stones; CholedocholithiasisLast Updated:February 20, 2017Unknown status
Condition(s):Pancreatic Cancer; Ampullary Cancer; Bile Duct Cancer; Cholangiocarcinoma, Extrahepatic; Cholangiocarcinoma Resectable; Cholangiocarcinoma of the Extrahepatic Bile Duct; Pancreatic Ductal Adenocarcinoma; Pancreatic Ductal Carcinoma; Surgery; Survivorship; Recurrent Cancer; Cancer Recurrent; Cancer Recurrence; Local Recurrence of Malignant Tumor of PancreasLast Updated:November 18, 2023Completed
Condition(s):Benign Pancreatic Neoplasm; Chronic Pancreatitis; Recurrent Acute PancreatitisLast Updated:February 8, 2024Not yet recruiting
Condition(s):Pancreatic CancerLast Updated:June 14, 2017Completed
Condition(s):Pancreas Cancer; Pancreas CystLast Updated:December 2, 2020Completed
Condition(s):CancerLast Updated:January 17, 2023Recruiting
Condition(s):Pancreatic Ductal AdenocarcinomaLast Updated:March 18, 2016Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.